The impact of the BCR-ABL oncogene in the pathology and treatment of chronic myeloid leukemia

This article offers a comprehensive analysis of the structural attributes of BCR-ABL, emphasizing its pivotal role as a biomarker and therapeutic target in CML. It underscores the imperative for ongoing research to refine treatment modalities and enhance overall outcomes in managing CML.PMID:38280275 | DOI:10.1016/j.prp.2024.155161

Source: Pathology, Research and Practice - January 27, 2024 Category: Pathology Authors: Mohamed El-Tanani Hamdi Nsairat Ismail I Matalka Yin Fai Lee Manfredi Rizzo Alaa A Aljabali Vijay Mishra Yachana Mishra Altijana Hromi ć-Jahjefendić Murtaza M Tambuwala Source Type: research